| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 06/05/2002 | EP0966430B1 Anti-inflammatory compounds |
| 06/05/2002 | EP0871443B1 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 06/05/2002 | EP0711282B1 Compounds as pde iv and tnf inhibitors |
| 06/05/2002 | CN1352636A Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 06/05/2002 | CN1085981C Nicotinic acid ester compounds and its salts, their preparation and medicine composition containing them |
| 06/05/2002 | CN1085980C Meta-guanidine, urea, thiourea or azacyclic amino benzoic and derivatives as integrin antagaonists |
| 06/04/2002 | US6399808 Reacting amine with carbon dioxide in anhydrous solvent |
| 06/04/2002 | US6399785 Multiply-substituted fullerenes |
| 06/04/2002 | US6399781 A key intermediate in the production of nevirapine, starting by reacting acetylacetaldehyde dimethyl acetal with malononitrile, in the presence of an ammonium salt catalyst |
| 06/04/2002 | US6399779 Aryl borates |
| 06/04/2002 | US6399656 Using a benzopyran-3-carboxamide compound |
| 06/04/2002 | US6399637 Crystal modification of torasemide |
| 06/04/2002 | US6399627 Anticoagulants; prothrominase, serine protease inhibitor; acrylamide derivatives |
| 06/04/2002 | US6399614 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring |
| 06/04/2002 | US6399613 N,n'-bis(2-hydroxyethyl)pyrazine-2,5- or -2,6-dicarboxamide; diabetes |
| 06/04/2002 | US6399606 3-(((2r)-2-(((2-fluorophenyl)amino)carbonylamino)-2-(methoxy carbonyl)ethylthio)methyl)-4-oxo-4-(3-pyridyl)butanoic acid; treatment of chemotherapy induced neuropathy |
| 06/04/2002 | US6399290 Silver halide imaging materials |
| 06/04/2002 | CA2067929C Piperazine derivatives |
| 05/30/2002 | WO2002043449A1 Luminescent element material and luminescent element comprising the same |
| 05/30/2002 | WO2002042276A1 Quarternary proforms of tertiary amine containing compounds |
| 05/30/2002 | WO2002042275A1 2-aryl-5-trifluoromethylpyridines |
| 05/30/2002 | WO2002042274A1 Process for producing 2-(4-pyridyl)ethanethiol |
| 05/30/2002 | WO2002042273A2 Acid derivatives useful as serine protease inhibitors |
| 05/30/2002 | WO2002042272A2 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| 05/30/2002 | WO2002042265A2 Cyanoguanidine prodrugs |
| 05/30/2002 | WO2002042262A2 Alkylthio- and aryl(heteroyl)thio-substituted p-phenylenediamines, their manufacture and their use in rubber |
| 05/30/2002 | WO2002042257A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
| 05/30/2002 | WO2002042250A1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES |
| 05/30/2002 | WO2002041978A1 Method for separating a phase transfer catalyst by means of a membrane |
| 05/30/2002 | WO2002022599A3 Chemokine receptor binding heterocyclic compounds |
| 05/30/2002 | WO2001074780A8 Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist |
| 05/30/2002 | WO2000076489A3 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 05/30/2002 | US20020065420 Method for producing pyridine compounds |
| 05/30/2002 | US20020065315 For therapy and prophylaxis of asthma, cystic fibrosis, chronic obstructive pulmonary disease and rhinorrhea, convulsions, vascular spasms, coronary artery spasms, renal disorders, polycystic kidney disease, bladder spasms, etc. |
| 05/30/2002 | US20020065304 As antitumor agent |
| 05/30/2002 | US20020065296 Administering heteroarylurea compound for therapy of cytokine mediated diseases and proteolytic enzyme mediated diseases |
| 05/30/2002 | US20020065282 Tetralone derivatives |
| 05/30/2002 | US20020065278 Non-imidazole aryloxyalkylamines |
| 05/30/2002 | US20020065264 Heterocylic leaving group containing -o-Het, or -s-Het, wherein Heterocyclic rings selected from pyridine, pyrole, furan, pyrimidine or proline derivatives |
| 05/30/2002 | US20020065230 Bis(aminomethyl)carbonyl compounds as inhibitors of cysteine protease (cathepsin K) and serine proteases; bone or cartilage loss, e.g., osteoporosis, periodontitis; antiarthritic agents; rheumatic diseases; gingivitis |
| 05/30/2002 | US20020064681 Luminescence device, display apparatus and metal coordination compound |
| 05/30/2002 | CA2430037A1 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| 05/30/2002 | CA2429328A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
| 05/30/2002 | CA2428191A1 Acid derivatives useful as serine protease inhibitors |
| 05/30/2002 | CA2426601A1 Cyanoguanidine prodrugs |
| 05/29/2002 | EP1208188A1 Composition and method for bleaching a substrate |
| 05/29/2002 | EP1208187A1 Method of bleaching stained fabrics |
| 05/29/2002 | EP1208186A1 Composition and method for bleaching a substrate |
| 05/29/2002 | EP1208185A2 Composition and method for bleaching a substrate |
| 05/29/2002 | EP1208184A1 Method of pretreating and bleaching stained fabrics |
| 05/29/2002 | EP1208107A2 Ligand and complex for catalytically bleaching a substrate |
| 05/29/2002 | EP1208091A1 Benzophenones as inhibitors of reverse transcriptase |
| 05/29/2002 | EP1208086A1 Benzamide formulation with histone deacetylase inhibitor activity |
| 05/29/2002 | EP1208085A2 Benzanilides as potassium channel openers |
| 05/29/2002 | EP1208084A1 Tetrahydropyridines as pesticides |
| 05/29/2002 | EP1207882A1 Acyclic and cyclic amine derivatives |
| 05/29/2002 | EP1207881A1 Pharmaceutical agent comprising a benzamide derivative as active ingredient |
| 05/29/2002 | EP1207880A1 Torsemide polymorphs |
| 05/29/2002 | EP1015501B1 Polymerisation catalysts |
| 05/29/2002 | EP0885886B1 Pyridinecarboxamide derivatives |
| 05/29/2002 | EP0837851B1 Fluorinated phenanthrene derivatives and their use in liquid crystal mixtures |
| 05/29/2002 | CN1351646A Composition and method for bleaching a substrate |
| 05/29/2002 | CN1351601A Heterocyclic compounds binding chemotactic factor receptor |
| 05/29/2002 | CN1351600A Process for preparing [S-(R*,S*)]-beta-[[[1-[1-OXO-3-(4-piperidinyl)propyl]-3-piperidinyl]amino]-3-pyridinepropanoic acid and derivatives |
| 05/29/2002 | CN1351592A Acyl derivatives which treat VL4-4 related disorders |
| 05/29/2002 | CN1351588A Inhibitors of LFA-l binding to ICAMs and uses thereof |
| 05/29/2002 | CN1085663C Aromatic amino ethers as pain relieving agents |
| 05/29/2002 | CN1085662C Process for preparing chloromethylpyridines |
| 05/28/2002 | US6395916 Amine, phosphine ligands |
| 05/28/2002 | US6395903 Reacting a quinoline in aqueous sulfuric acid or nitric acid solution with ozone, and then reacting the resulting peroxide solution with an oxidizing agent; adjusting the ph to 0.2 to 3; cooling to 0-30 degrees c.; isolation |
| 05/28/2002 | US6395902 Oxathiazolidinyl pyridines |
| 05/28/2002 | US6395737 Malonic acid derivatives, processes for their preparation, for their use and pharmaceutical compositions containing them |
| 05/28/2002 | US6395735 An indane-like compounds which can be useful for treating psychosis and other conditions associated with modulation of a muscarinic receptor |
| 05/28/2002 | US6395731 Anticoagulants |
| 05/28/2002 | US6395713 Cationic lipidcationic lipid |
| 05/28/2002 | US6395367 Electroconductivity |
| 05/28/2002 | US6395351 Mixture; optics |
| 05/23/2002 | WO2002040475A1 Bombesin receptor antagonists |
| 05/23/2002 | WO2002040466A2 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders |
| 05/23/2002 | WO2002040456A1 Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor |
| 05/23/2002 | WO2002040448A1 Pyridone derivatives as ap2 inhibitors |
| 05/23/2002 | WO2002040431A2 Compounds having fungicidal activity and processes to make and use same |
| 05/23/2002 | WO2002040022A1 Treatment of sexual dysfunction using bombesin antagonist |
| 05/23/2002 | WO2002040008A2 Treatment of sexual dysfunction with non peptide bombesin receptor antagonists |
| 05/23/2002 | WO2002039969A1 Novel coupler for use in oxidative hair dyeing |
| 05/23/2002 | WO2002004419A3 α,α-DIBROMO-α-CHLORO-ACETOPHENONES AS SYNTHONS |
| 05/23/2002 | WO2001081316A3 Substituted phenyl farnesyltransferase inhibitors |
| 05/23/2002 | WO2001041760A9 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 05/23/2002 | US20020062025 Reacting a quinoline in aqueous sulfuric acid or nitric acid solution with ozone, and then reacting the resulting peroxide solution with an oxidizing agent; adjusting the pH to 0.2 to 3; cooling to 0-30 degrees C.; isolation |
| 05/23/2002 | US20020061987 Polymerization of ethylene |
| 05/23/2002 | US20020061890 Angiogenesis inhibiting 5-substituted-1,2,4,-thiadiazolyl derivatives |
| 05/23/2002 | US20020061887 For therapy and prophylaxis of cardiovascular diseases such as hypertension, angina pectoris, cardiac insufficiency, thromboses or atherosclerosis |
| 05/23/2002 | US20020061886 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof |
| 05/23/2002 | US20020061881 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 05/23/2002 | US20020061872 For oral administration or embedded or otherwise attached to medical devices for blood collection and/or treatment |
| 05/23/2002 | US20020061844 Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt |
| 05/23/2002 | DE10057911A1 New heterocyclic acylsulfimide derivatives, useful as insecticides, acaricides and nematocides for plant protection or in veterinary medicine |
| 05/23/2002 | CA2448729A1 Piperazinyl and piperidyl substituted heterocyclic compounds |
| 05/23/2002 | CA2436854A1 Pyridone derivatives as ap2 inhibitors |
| 05/23/2002 | CA2429329A1 Bombesin receptor antagonists |